EMJ GOLD - European Medical Journal

This site is intended for healthcare professionals

Continue

EMJ GOLD

Filter Advertise With Us

Pharma Supply Chains Face Record Pressure as Four Risks Converge

Pharmaceutical supply chains under mounting pressure from geopolitical disruption, manufacturing fragility, cyber threats and counterfeit medicines, Moody’s report warns risks require a more integrated approach to resilience.
England launches MenB vaccine programme for students

England launches one-off MenB vaccination programme for students

According to a UK government announcement, thousands of young people in England will be offered a two-dose MenB vaccine ahead of the 2026 academic year.
Pharmacist compounding a drug

FDA steps up crackdown on compounded GLP-1s

Around 1.5 million Americans are taking compounded GLP-1 drugs despite the end of US shortages.
GSK office building

GSK to acquire Nuvalent for $10.6bn ahead of patent cliff

The purchase, GSK’s biggest in over a decade, includes two late-stage lung cancer drugs primed for FDA approval.

Gavi commits $50m to Bundibugyo Ebola virus vaccines

Gavi has committed $50m to efforts towards vaccine approval for the Ebola virus outbreak in the Democratic Republic of the Congo and Uganda, caused by the Bundibugyo virus.
Injectable pen

Boehringer posts mixed obesity drug phase 3 results

Despite the positive efficacy data, investor attention has turned to survodutide’s tolerability profile.
White DNA helix on blue background

FDA unveils new plan for genome therapy editing

The guidance allows sponsors to build on data generated from previous R&D programmes.
Person holding a wax model of ovaries in their palms

NHS rolls out first new ovarian cancer drug in 20 years

The targeted therapy will be available for patients with epithelial ovarian, peritoneal, or fallopian tube cancers.
Month in pharma news, explained

Month in pharma news, explained – May 2026

From a potential breakthrough in pancreatic cancer to fresh Ebola concerns and more FDA leadership turmoil, discover the most-read stories.

Trial points to breakthrough in cancer metastasis prevention

A phase 2a study has revealed encouraging early evidence for cancer metastasis prevention, with fewer metastatic recurrences and no metastasis-related deaths in treated patients.
Two scientists in a lab

CEPI pledges $61.8m to fast-track Ebola vaccines

There is no licensed vaccine for the current Bundibugyo strain, with three vaccine makers hoping they hold the key.

Eight countries pledge $175m for women’s health supplies

Ethiopia, Ghana, Honduras, Nigeria, Senegal and Zambia, Belgium and Luxembourg have scaled-up commitments to women’s reproductive healthcare.

Alcohol deaths drop as treatment landscape expands

Alcohol-specific deaths have dropped in the UK, as the market for accessible, evidence-based treatment expands.
Trophy with stars spilling out of it on purple background

EMJ named among The Sunday Times Best Places to Work 2026

EMJ achieved high scores across several key workplace culture metrics, including trust, purpose and respect.
Eli Lilly office building, with a plane flying overhead

Lilly buys trio of vaccine biotechs for $3.83bn

Eli Lilly spends big on three biotech deals as it targets vaccines and infection prevention in a major strategic shift.
Person holding a single pill in their hand

Europe set to get first oral GLP-1 weight loss pill

The European Medicines Agency has recommended the approval of Novo Nordisk’s semaglutide pill for weight loss.
AI Medical Imaging Market Growth Accelerates - EMJ

AI medical imaging market set for rapid growth

The global AI medical imaging market is projected to grow rapidly as healthcare systems adopt AI tools to improve diagnostics and reduce radiologist workload.
Scales and a tape measure on a blue background

Obesity care missing where demand is greatest, study shows

A global study into obesity rates around the world has revealed stark gaps.
Vial with hantavirus label on it

UK accepts hantavirus antiviral doses from Japan

Japan has supplied the UK with an experimental antiviral drug, favipiravir, as a precautionary measure.
Ebola virus

Ebola outbreak renews focus on broad-spectrum antivirals

Rising Bundibugyo Ebola cases in DRC and Uganda have highlighted treatment gaps.

MHRA launches UK-wide gene therapy consultation

The MHRA has launched a consultation calling to update the legal definition of gene therapy medicinal products.
US flag against blue sky

US cancer centres inundated for new pancreatic cancer drug

After daraxonrasib’s phase 3 trial results were released, there has reportedly been “a deluge of patient requests”.

NHS expands blood testing for cancer patients

Sophia Genetics and Synnovis are scaling liquid biopsy testing across England, helping cancer patients access AI-driven genomic analysis.
FDA office building

FDA commissioner resigns after 13 months in post

Dr Marty Makary has resigned as commissioner of the FDA after a troubled time in office, following sustained pressure.

GSK to sell hepatitis B drug in China through SBP Group

GSK has entered a new deal with Sino Biopharmaceutical to rollout a new chronic hepatitis B drug in China.

Pharma supply chains reshaped by tariffs and geopolitics

New US tariff measures and mounting, acute geopolitical tensions are reshaping the global pharmaceutical landscape, GlobalData reported.
Hand holding the brain

Angelini buys US brain health firm Catalyst for $4.1bn

The deal marks the company’s first acquisition since 2021 and a step forward in its mission to lead in brain health.
Month in pharma news, explained

Month in pharma news, explained – April 2026

Here is your April 2026 pharma news roundup. It’s time to reflect on a big month for weight loss drugs and more.

FDA authorises first fruit-flavoured vapes

The FDA, on 5 May, authorised the marketing of fruit-flavoured e-cigarettes – the first vapes allowed for sale that are not tobacco or menthol flavoured.
Skis upright in the snow on a mountain

Novartis to sponsor Special Olympics World Winter Games

The Games bring together athletes with cognitive disabilities to compete in elite winter sports such as skiing.
The phrase abortion pill written in an article and highlighted

Abortion pill access upheld by Supreme Court

The remote prescription of mifepristone is under threat from a lawsuit by Louisiana.

LEO Pharma acquires Replay for $50m

LEO Pharma has acquired Replay’s herpes simplex virus gene therapy platform for $50m upfront.
City of Cambridge

£450m invested in UK by AZ and Boehringer

In good news for UK life sciences investment, two companies have made pledges to build new facilities.
Person standing on scale, with tape measure on the floor

Boehringer drug hits 16.6% weight loss in phase 3

The therapy survodutide works by reducing appetite while also targeting metabolism in the liver.

EMJ Podcast shortlisted for 2026 PPA Awards

The EMJ Podcast is a finalist for Audio Content of the Year at the 2026 PPA Awards, shortlisted from more than 260 entries reviewed by a panel of experts.

EMJ shortlisted for The Drum Awards for Marketing 2026

The European Medical Journal has been shortlisted for The Drum Awards for Marketing 2026, for its interactive digital tool combatting COPD diagnostic delays.
Mosquito on a limb with a red filter over the image

WHO backs first malaria treatment for newborns

Until now, there had been no approved malaria treatment for infants weighing less than 4.5kg.
Sign with Novo Nordisk

Oral semaglutide shows promise in paediatric type 2 diabetes

A phase 3 trial has shown efficacy in type 2 diabetes for adolescents, positioning it as a potential first oral solution for this population.

Moderna initiates phase 3 bird flu vaccine trial

A phase 3 study of Moderna’s investigational mRNA-based H5 pandemic influenza vaccine candidate has been initiated.

US court blocks CDC vaccine advisory panel appointments

A US court issued a preliminary injunction last month to freeze ACIP appointments, raising vaccination concerns for the upcoming respiratory disease season.
We’ve noticed you’re accessing
from North/South America.